KEGG   DRUG: Clesrovimab
Entry
D12153                      Drug                                   
Name
Clesrovimab (USAN);
Clesrovimab (genetical recombination) (JAN);
Clesrovimab-cfor;
Enflonsia (TN)
Product
Formula
C6526H10118N1732O2039S40
Exact mass
146655.0116
Mol weight
146745.22
Sequence
(Heavy chain)
EVQLVESGGG LVRPGRSLRL SCTVSGFSFD DSAMSWVRQA PGKGLEWISF IKSKTYGGTK
EYAASVKGRF TISRDDSKNI AYLQMNSLKT EDTAVYYCTR GAPYGGNSDY YYGLDVWGQG
TTVTVSSAST KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF
PAVLQSSGLY SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKKVEPKSC DKTHTCPPCP
APELLGGPSV FLFPPKPKDT LYITREPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK
PREEQYNSTY RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT
LPPSRDELTK NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL
TVDKSRWQQG NVFSCSVMHE ALHNHYTQKS LSLSPGK
(Light chain)
DIQMTQSPSS LSASVGDRVT ITCRTSQDVR GALAWYQQKP GKAPKLLIFD ASSLETGVPS
RFSGSGSGTV FTLTISSLQP EDFAAYYCQQ FLDFPFTFGQ GTRLEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: H22-H98, H154-H210, H230-L214, H236-H'236, H239-H'239, H271-H331, H377-H435, H'22-H'98, H'154-H'210, H'230-L'214, H'271-H'331, H'377-H'435, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  Type
Peptide
Remark
Product: D12153<US>
Efficacy
Antiviral
  Disease
RSV lower respiratory tract disease [DS:H00401]
  Type
Monoclonal antibody
Comment
Prevention of respiratory syncytial virus (RSV) infection
Target
RSV F protein [KO:K19261]
Brite
Antimicrobials [BR:br08307]
 Antivirals
  Entry, fusion or uncoating inhibitor
   RSV F protein
    D12153  Clesrovimab (USAN)
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D12153
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D12153
Other DBs
CAS: 2429913-18-6
PubChem: 497620566
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system